Literature DB >> 21499878

Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan.

Chung-Ming Huang1, Po-Hao Huang, Chi-Lan Chen, Ying-Ju Lin, Chang-Hai Tsai, Wen-Liang Huang, Fuu-Jen Tsai.   

Abstract

The purpose of this study was to determine whether toll-like receptor 9 (TLR9) gene polymorphisms were markers of susceptibility to or severity of systemic lupus erythematosus (SLE) in Taiwanese patients. The study included 211 healthy individuals and 167 Chinese patients with SLE. Polymorphisms of TLR9 [rs2066807 and rs187084 (-1486 T/C)] were typed from genomic DNA. The genotypes, allelic frequencies, and carriage rates were compared between patients with SLE and control subjects. The relationship between allelic frequencies and clinical manifestations of 167 patients with SLE was evaluated. There was no statistically significant difference in TLR9 (rs2066807) gene polymorphism, allelic frequency, and carriage rate between the SLE and control groups. However, for the genotype of TLR9 -1486 T/C (rs187084) polymorphism, there was a statistically significant difference between the SLE and the control groups (P < 0.001, χ(2) = 15.9). Moreover, there was a significant association between the two groups in allelic frequency and carriage rate of the T allele (P < 0.001, χ(2) = 18.5 and P < 0.01, χ(2) = 8.06, respectively). We did not detect any association between the TLR9 genotype and the clinical or laboratory profiles in patients with SLE. The results suggest that the TLR9 -1486 T/C (rs187084), but not TLR9 (rs2066807), polymorphism is related to SLE in Taiwanese patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499878     DOI: 10.1007/s00296-011-1925-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  16 in total

Review 1.  The methyl-CpG binding domain and the evolving role of DNA methylation in animals.

Authors:  Brian Hendrich; Susan Tweedie
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

2.  Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese.

Authors:  M W Ng; C S Lau; T M Chan; W H S Wong; Y L Lau
Journal:  Rheumatology (Oxford)       Date:  2005-09-27       Impact factor: 7.580

3.  Association study of Toll-like receptor 9 gene polymorphism in Korean patients with systemic lupus erythematosus.

Authors:  J-W Hur; H D Shin; B L Park; L H Kim; S-Y Kim; S-C Bae
Journal:  Tissue Antigens       Date:  2005-03

4.  Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.

Authors:  Elizabeth A Leadbetter; Ian R Rifkin; Andreas M Hohlbaum; Britte C Beaudette; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Nature       Date:  2002-04-11       Impact factor: 49.962

5.  Toll-like receptor expression in lupus peripheral blood mononuclear cells.

Authors:  Kiyoshi Migita; Taichiro Miyashita; Yumi Maeda; Minoru Nakamura; Hiroshi Yatsuhashi; Hironori Kimura; Hiromi Ishibashi; Katsumi Eguchi
Journal:  J Rheumatol       Date:  2007-03       Impact factor: 4.666

6.  Activation of autoreactive B cells by CpG dsDNA.

Authors:  Gregory A Viglianti; Christina M Lau; Timothy M Hanley; Benjamin A Miko; Mark J Shlomchik; Ann Marshak-Rothstein
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

Review 7.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

8.  Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.

Authors:  Lixin Rui; Carola G Vinuesa; Julie Blasioli; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2003-05-11       Impact factor: 25.606

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Systemic autoimmune disease arises from polyclonal B cell activation.

Authors:  D M Klinman; A D Steinberg
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Integration of B cell responses through Toll-like receptors and antigen receptors.

Authors:  David J Rawlings; Marc A Schwartz; Shaun W Jackson; Almut Meyer-Bahlburg
Journal:  Nat Rev Immunol       Date:  2012-03-16       Impact factor: 53.106

Review 2.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 3.  TLR9 polymorphisms and systemic lupus erythematosus risk: an update meta-analysis study.

Authors:  Duan Wang; Chao Zhang; Zongke Zhou; Fuxing Pei
Journal:  Rheumatol Int       Date:  2015-12-07       Impact factor: 2.631

Review 4.  From autoinflammation to autoimmunity: old and recent findings.

Authors:  Francesco Caso; Luisa Costa; Valeria Nucera; Giuseppe Barilaro; Ignazio Francesco Masala; Rossella Talotta; Paolo Caso; Raffaele Scarpa; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Clin Rheumatol       Date:  2018-07-16       Impact factor: 2.980

5.  Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer's disease in Han Chinese.

Authors:  Ying-Li Wang; Meng-Shan Tan; Jin-Tai Yu; Wei Zhang; Nan Hu; Hui-Fu Wang; Teng Jiang; Lan Tan
Journal:  J Neuroinflammation       Date:  2013-08-20       Impact factor: 8.322

6.  Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia

Authors:  Yasser B.M Ali; Rasha M Foad; Essam Abdel-Wahed
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-29

Review 7.  Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification.

Authors:  Vince Kornél Grolmusz; Anikó Bozsik; János Papp; Attila Patócs
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

8.  Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.

Authors:  Teja Celhar; Anna-Marie Fairhurst
Journal:  Front Pharmacol       Date:  2014-12-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.